← Back to Search

Intervention for COVID-19 (VIGIE-COVID Trial)

N/A
Waitlist Available
Led By Jean-Sébastien Paquette
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

VIGIE-COVID Trial Summary

Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens

Eligible Conditions
  • Citizen Self-Reported Symptoms
  • Tailored Recommendations
  • COVID-19

VIGIE-COVID Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
improvement in daily fruit consumption
improvement in hand washing behavior
improvement in mask wearing behavior
+3 more
Secondary outcome measures
Platform participation
Platform sustainability long term
Platform sustainability short term

VIGIE-COVID Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention arm are participants who will receive tailored recommendations about health prevention in a pandemic based on their answers in the survey.
Group II: ControlActive Control1 Intervention
The control group will receive general recommendations about health prevention in a pandemic.

Find a Location

Who is running the clinical trial?

Réseau de recherche en santé des populations du QuébecUNKNOWN
Laval UniversityLead Sponsor
417 Previous Clinical Trials
171,072 Total Patients Enrolled
4 Trials studying COVID-19
7,885 Patients Enrolled for COVID-19
Réseau-1 QuébecUNKNOWN
1 Previous Clinical Trials
3 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~272 spots leftby Apr 2025